Arterys Cardio DL vs SignalHF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Arterys (now part of Tempus)
VS
by Implicity

AI Verdict

Arterys Cardio DL is designed to enhance diagnostic accuracy and efficiency for cardiac MRI analysis by providing automated ventricle segmentations. In contrast, SignalHF by Implicity focuses on predicting heart failure hospitalizations within 30 days through the analysis of data from cardiac implantable electronic devices. While both are cardiology AI tools, they address different clinical needs and utilize distinct data modalities for their respective functions.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is rapid, accurate, and automated analysis of cardiac MRI studies. This tool is ideal for cardiologists and radiologists seeking to drastically reduce interpretation time for ventricle segmentations, perform advanced 4D Flow post-processing, or conduct quantitative delayed enhancement analysis to enhance diagnostic precision.

View Arterys Cardio DL →

Choose SignalHF if…

Choose SignalHF if your objective is to proactively manage heart failure patients with cardiac implantable electronic devices (CIEDs) and prevent hospitalizations. This AI algorithm is best suited for care teams looking to predict heart failure hospitalizations within 30 days by leveraging CIED data, enabling timely interventions and personalized care plans.

View SignalHF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL SignalHF
Pricing Unknown Contact for pricing
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] SaaS
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL SignalHF
Name Arterys Cardio DL SignalHF
Company ARTERYS Implicity
Description FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Primary Function Automated, editable ventricle segmentations for cardiac MRI analysis Predicts heart failure hospitalizations within 30 days
Key Feature 1 Automated ventricle segmentations for cardiac MRI FDA-cleared AI algorithm for heart failure prediction
Key Feature 2 Deep learning algorithms for image analysis Predicts heart failure hospitalizations within 30 days
Specialties Cardiology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and SignalHF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is designed for cardiac MRI analysis, providing automated ventricle segmentations to reduce interpretation time and enhance diagnostic accuracy. SignalHF by Implicity focuses on predicting heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices (CIEDs).
Arterys Cardio DL integrates into cardiac MRI interpretation workflows, offering rapid analysis of images and editable automated contours. SignalHF integrates with CIED data management, providing automatic alerts and risk scores to care teams for early intervention in heart failure management.
Arterys Cardio DL provides automated ventricle segmentations, 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. SignalHF generates predictive risk scores and automatic alerts for heart failure hospitalizations based on physiological data, demographics, and CIED measurements.
Arterys Cardio DL is described as vendor-agnostic compatible, suggesting broad compatibility with cardiac MRI systems. SignalHF offers manufacturer-agnostic compatibility with various CIEDs, including pacemakers, ICDs, and CRTs.
Arterys Cardio DL drastically reduces cardiac MRI interpretation time from 30-60 minutes to seconds, enhancing diagnostic accuracy. SignalHF enables early intervention and personalized care plans by predicting heart failure hospitalizations, aiming to improve patient outcomes.

Backers

Who funded each tool's parent company.

SignalHF

AI Tool Finder
AI-powered search. Results may not be comprehensive.